Scarica l'app Stockscreener
1.61
4.17%
-0.07
Dopo l'orario di chiusura:
1.61
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Medicinova Inc Borsa (MNOV) Ultime notizie
MediciNova (NASDAQ:MNOV) Now Covered by StockNews.com - Defense World
StockNews.com Begins Coverage on MediciNova (NASDAQ:MNOV) - MarketBeat
MediciNova (NASDAQ:MNOV) Shares Cross Above Two Hundred Day Moving Average – Should You Sell? - Defense World
MediciNova Announces Update of Phase 2/3 Clinical Trial of - GlobeNewswire
MediciNova Announces Update of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS patients (COMBAT-ALS) at the 2024 Annual NEALS Meeting (Northeast Amyotrophic Lateral Sclerosis Consortium) - StockTitan
MediciNova (NASDAQ:MNOV) Research Coverage Started at StockNews.com - Defense World
MediciNova (NASDAQ:MNOV) Now Covered by Analysts at StockNews.com - MarketBeat
TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail
MediciNova, Inc. (NASDAQ:MNOV) Shares Sold by Dimensional Fund Advisors LP - Defense World
MediciNova (NASDAQ:MNOV) shareholders have endured a 73% loss from investing in the stock five years ago - Yahoo Finance
MediciNova (NASDAQ:MNOV) Earns Hold Rating from Analysts at StockNews.com - MarketBeat
MNOV: MN-166 to be Evaluated in NIH-Sponsored Expanded Access Trial in ALS - Smartkarma
MNOVMedicinova, Inc. Latest Stock News & Market Updates - StockTitan
Short Interest in MediciNova, Inc. (NASDAQ:MNOV) Rises By 19.3% - MarketBeat
MediciNova to Support NIH-Funded Expanded Access Clinical - GlobeNewswire
MediciNova to Support NIH-Funded Expanded Access Clinical Trial to Evaluate MN166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS) - StockTitan
MediciNova (NASDAQ:MNOV) Stock Crosses Above 200-Day Moving Average of $1.42 - MarketBeat
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Stockhouse Publishing
Insigneo Advisory Services LLC Has $6.10 Million Stock Position in Mastercard Incorporated (NYSE:MA) - Defense World
Intech Investment Management LLC Takes Position in MSA Safety Incorporated (NYSE:MSA) - MarketBeat
Minerals Technologies (NYSE:MTX) Upgraded at StockNews.com - MarketBeat
Monroe Capital (NASDAQ:MRCC) Stock Crosses Above 200 Day Moving Average of $7.49 - MarketBeat
MARXU stock soars to all-time high of $12.15 amid market optimism - Investing.com Australia
Marcus (NYSE:MCS) Upgraded by StockNews.com to Hold - Defense World
Mistras Group senior EVP sells over $349k in company stock - Investing.com
Contact Levi & Korsinsky by September 24, 2024 Deadline to Join Class Action Against MacroGenics, Inc.(MGNX) - Stockhouse Publishing
Summit Trail Advisors LLC Buys 403 Shares of Moderna, Inc. (NASDAQ:MRNA) - Defense World
MacroGenics, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationMGNX - Longview News-Journal
MasterBrand (NYSE:MBC) Hits New 52-Week High at $19.10 - MarketBeat
ProShare Advisors LLC Sells 43,073 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Mutual of America Capital Management LLC Cuts Position in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World
Mutual of America Capital Management LLC Decreases Stake in MSA Safety Incorporated (NYSE:MSA) - Defense World
2024-09-23 | Shareholders that lost money on MacroGenics, Inc.(MGNX) Urged to Join Class ActionContact The Gross Law Firm to Learn More | NDAQ:MGNX | Press Release - Stockhouse Publishing
King Luther Capital Management Corp Buys 13,051 Shares of Mercury Systems, Inc. (NASDAQ:MRCY) - Defense World
Hagens Berman Reminds MacroGenics (MGNX) Investors of the - GlobeNewswire
Legacy Financial Advisors Inc. Grows Stock Position in Mastercard Incorporated (NYSE:MA) - Defense World
XTX Topco Ltd Purchases 1,054 Shares of Martin Marietta Materials, Inc. (NYSE:MLM) - Defense World
Edgestream Partners L.P. Invests $1.67 Million in Moderna, Inc. (NASDAQ:MRNA) - Defense World
Down 13% in 1 Day, Is Moderna Stock in Trouble? - The Motley Fool
StockNews.com Initiates Coverage on MediciNova (NASDAQ:MNOV) - MarketBeat
Traders Purchase High Volume of Moderna Put Options (NASDAQ:MRNA) - Defense World
Clear Street LLC Acquires 1,335 Shares of Metal Sky Star Acquisition Co. (NASDAQ:MSSA) - Defense World
MGNX Stockholders Have Opportunity to Lead MacroGenics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - AccessWire
MacroGenics (NASDAQ:MGNX) Lifted to “Strong-Buy” at Evercore ISI - Defense World
Hagens Berman Reminds MacroGenics (MGNX) Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of Sept. 24, 2024 - ForexTV.com
The Gross Law Firm Notifies MacroGenics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – MGNX - EIN News
Parallel Advisors LLC Reduces Position in Moderna, Inc. (NASDAQ:MRNA) - Defense World
Barclays Lowers Mplx (NYSE:MPLX) Price Target to $45.00 - Defense World
Comparing Prestige Consumer Healthcare (NYSE:PBH) and MediciNova (NASDAQ:MNOV) - Defense World
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against MacroGenics, Inc.MGNX - Longview News-Journal
Bank of New York Mellon Corp Purchases 324 Shares of MakeMyTrip Limited (NASDAQ:MMYT) - Defense World
2024-09-16 | Investors in MacroGenics, Inc. Should Contact Levi & Korsinsky Before September 24, 2024 to Discuss Your RightsMGNX | NDAQ:MGNX | Press Release - Stockhouse Publishing
MediciNova, Inc. (NASDAQ:MNOV) Sees Large Increase in Short Interest - MarketBeat
Moderna (NASDAQ:MRNA) PT Lowered to $115.00 - Defense World
MediciNova Announces Abstract Regarding MN-166 (ibudilast) - GlobeNewswire
MediciNova Announces Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial Accepted for Poster Presentation at the 35th International Symposium on ALS / MND - StockTitan
MediciNova (NASDAQ:MNOV) Stock Price Crosses Above 200-Day Moving Average of $1.36 - Defense World
MediciNova Announces Acceptance of Abstract Regarding - GlobeNewswire
MediciNova Announces Acceptance of Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial for Presentation at the 2024 Annual NEALS (Northeast Amyotrophic Lateral Sclerosis Consortium) Meeting - Yahoo Finance UK
2.02%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):